Translational Development Acquisition Corp. (TDAC)

TDAC Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Selling, General & Admin	0.54	0.2	0.49	0.07
Operating Expenses	0.54	0.2	0.49	0.07
Operating Income	-0.54	-0.2	-0.49	-0.07
Interest & Investment Income	1.96	0.13	-	-
Pretax Income	1.41	-0.07	-0.49	-0.07
Net Income	1.41	-0.07	-0.49	-0.07
Net Income to Common	1.41	-0.07	-0.49	-0.07
Shares Outstanding (Basic)	9	4	4	4
Shares Outstanding (Diluted)	9	4	4	4
Shares Change (YoY)	118.69%	8.46%	-	-
EPS (Basic)	0.16	-0.02	-0.12	-0.02
EPS (Diluted)	0.16	-0.02	-0.12	-0.02
EBIT	-0.54	-0.2	-0.49	-0.07

Updated Nov 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q